Research Article

Characterization of Epithelial-Mesenchymal Transition Identifies a Gene Signature for Predicting Clinical Outcomes and Therapeutic Responses in Bladder Cancer

Figure 4

The gene signature serves as a robust and promising predictive factor for survival prediction. Kaplan–Meier survival curves illustrate worse survival outcomes in high-risk patients in the TCGA training cohort (a, c, e), validation I cohort (g, i), and validation II cohort (k). ROC curves for 1-year, 3-year, and 5-year survival prediction depict that this gene signature has a promising and stable predictive performance for BC patients in the training cohort (b, d, f), validation I cohort (h, j), and validation II cohort (l).